Back
Allegion Plc 10K Form
Sell
28
ALLE
Allegion Plc
Last Price:
$162.16
Seasonality Move:
3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | ALLE/Allegion Plc Quarterly |
| 2023-10-31 | 10Q | ALLE/Allegion Plc Quarterly |
| 2023-07-26 | 10Q | ALLE/Allegion Plc Quarterly |
| 2023-04-26 | 10Q | ALLE/Allegion Plc Quarterly |
| 2022-10-27 | 10Q | ALLE/Allegion Plc Quarterly |
| 2022-07-28 | 10Q | ALLE/Allegion Plc Quarterly |
Receive ALLE News And Ratings
See the #1 stock for the next 7 days that we like better than ALLE
ALLE Financial Statistics
Sales & Book Value
| Annual Sales: | $4.1B |
|---|---|
| Cash Flow: | $199.6M |
| Price / Cash Flow: | 19.84 |
| Annual Sales: | $24.02 |
| Price / Book: | 6.75 |
Profitability
| EPS (TTM): | 7.43890 |
|---|---|
| Net Income (TTM): | $643.8M |
| Gross Margin: | $1.8B |
| Return on Equity: | 36.14% |
| Return on Assets: | 13.18% |
Allegion Plc Earnings Forecast
Key Allegion Plc Financial Ratios
-
The Gross Profit Margin over the past 15 years for ALLE is 45.20%.
-
The Selling, General & Administrative Expenses for ALLE have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 3.25% of Revenue.
-
The Interest Expense is 15.69% of Operating Income.
-
The Net Earning history of ALLE is 15.83% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Allegion Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Building Products |
| Sector: | Industrials |
| Current Symbol: | ALLE |
| CUSIP: | G0176J |
| Website: | allegion.com |
Debt
| Debt-to-Equity Ratio: | 1.04 |
|---|---|
| Current Ratio: | 1.84 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.81 |
|---|---|
| Forward P/E Ratio: | 17.17 |
ALLE Technical Analysis vs Fundamental Analysis
Sell
28
Allegion Plc (ALLE)
is a Sell
Is Allegion Plc a Buy or a Sell?
-
Allegion Plc stock is rated a SellThe current Allegion Plc [ALLE] share price is $162.14. The Score for ALLE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.